Safety and Efficacy of Drug-Eluting Bead Transarterial Chemoembolization Combined with Lenvatinib and Anti-PD-1 Antibodies for Unresectable Hepatocellular Carcinoma: A Retrospective Analysis - Concepedia

Concepedia

Publication | Open Access

Safety and Efficacy of Drug-Eluting Bead Transarterial Chemoembolization Combined with Lenvatinib and Anti-PD-1 Antibodies for Unresectable Hepatocellular Carcinoma: A Retrospective Analysis

DOI Full Paper Access

14

Citations

32

References

2023

Year

Shaojie Wu, Dan‐dan Ruan, Qiuyan Wu, Yi Tang, Jianhui Zhang, Senlin Cai, Yanfeng Zhou, Jie-wei Luo, Zhu-ting Fang

Journal of Hepatocellular Carcinoma

Abstract

DEB-TACE combined with LEN and PD-1 inhibitors has a high ORR and surgical conversion rate in the treatment of uHCC tumors, and the toxicity and side effects were tolerable.

References

	Year	Citations

Page 1